Cyclosporine A reduction and withdrawal in liver transplantation: a risk-benefit analysis

Transplant Proc. 1997 Nov;29(7):2819-21. doi: 10.1016/s0041-1345(97)00691-x.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Alanine Transaminase / blood
  • Aspartate Aminotransferases / blood
  • Blood Pressure
  • Creatinine / blood
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use*
  • Female
  • Glucose Tolerance Test
  • Graft Rejection / epidemiology
  • Graft Rejection / immunology
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Liver Function Tests
  • Liver Transplantation / immunology*
  • Liver Transplantation / physiology
  • Male
  • Middle Aged
  • Postoperative Complications / epidemiology
  • Risk Assessment
  • Time Factors
  • gamma-Glutamyltransferase / blood

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Creatinine
  • gamma-Glutamyltransferase
  • Aspartate Aminotransferases
  • Alanine Transaminase